---
title:    Sutures
author:   Salpy Kelian  
date:     June, 2017  
CSS: main.css    
---

# Reference Values #

## Serum ##
|	| Normal Range	|  
| ------	| ------	|  
| pH	| 7.35-7.45 (7.40)	|  
| pO~2~	| 70-100 mmHg (90 mmHg)	| 
| pCO~2~	| 34-45 mmHg (40 mmHg)	|  
| HCO~3~^-^	| 22-25 mEq/L (24 mEq/L)	|  
| sO~2~	| >95%	|  
| Na^+^	| 135-145 mEq/L	|  
| K^+^	| 3.5-5.0 mEq/L	|  
| Cl^-^	| 95-105 mEq/L	|  
| Mg^2+^	| 1.5-2.5 mEq/L	|  
| Ca^2+^ (total)	| 2.2-2.6 mM	|  
| Osmolality 	| 280-325 mOSm	|  
| Glucose 	| 4.2-5.6 mM (fasting)	|  

## Serum - Inflammatory ##
|	| Normal Range	|  
| ------	| ------	|
| CRP	| <10 mg/L (<1.0 mg/dL)	|  
| ESR	| 0-20 mm/h	| 


## Serum - Kidney ##
|	| Normal Range	|  
| ------	| ------	|  
| BUN	| 2.5-6.4 mM (7-18 mg/dL)	|  
| Cr	| M: 53-106 &mu;M (0.6-1.2 mg/dL)<br/>F: 44-80 &mu;M (0.5-0.9 mg/dL)	|  
| 
 
## Serum - Liver ##
|	| Normal Range	|  
| ------	| ------	|  
| ALT	| 8-20 U/L	|  
| AST	| 12-38 U/L	|  
| GGT	| M: 9-50 U/L<br/>F:8-40 U/L	|  
| ALP	| 30-120 U/L	|  
| Bilirubin total	| 5.1 - 22 &mu;M (0.3-1.3 mg/dL)	|  
| Bilirubin - direct<br/>(conjugated)	| 1.7-6.8 &mu;M (0.1-0.4 mg/dL)	|  
| Bilirubin - indirect<br/>(unconjugated)	| 3.4-15.2 &mu;M (0.2-0.9 mg/dL)	|  
|Total protein	| 60-84 g/L (6.0-8.4 g/dL)
| Albumin	| 40-55 g/L (4.0-5.5 g/dL)	|  

## Serum - Pancreas ##

|	| Normal Range	|  
| ------	| ------	|  
| Amylase	| 20-96 U/L	|  
| Lipase	| 3-43 U/L	|  

## Serum - Hematology ##
|	| Normal Range	|  
| ------	| ------	|  
| Hb	| M: 130-180 g/L<br/>F:115-165 g/L	|  
| WBC	| 4.5-11 x 10^9^ /L	|  
| Platelets	| 150-450 x 10^9^ /L	|  
| RBC	| M: 4.3-5.6 x 10^12^/L<br/>F: 4.0-5.2 x 10^12^/L	| 
|Hematocrit (Hct)	| M: 45-62 % <br/>F: 37-48 %	|  
| MCV	| 80-95 fL	|  
|  Prothrombin Time (PT)	| 12.7-15.4 s	|  
| Partial Thromboplastin Time (PTT)	| 60-70 s	| 
| Activated Partial Thromboplastin Time (aPTT)	| 25-35 s	|  
| International Normalized Ratio (INR)<br/>	| 0.8-1.1	| 

### PT, aPTT, INR ###
Mnemonic PeT and PiTT: 

* P**e**T = **e**xtrinsic pathway
* P**i**TT = **i**ntrinsic pathway.

|| INR (PT)	| PTT	|  
|-----|  ------	| ------	|  
|pathway| extrinsic pathway	| intrinsic pathway	|  
|coagulation factors| VII, X, V, II, I	| XII, XI, IX, VIII, X, V, II, I	|  
|used to monitor	| warfarin (INR target of 2-3)	| heparin*  (aPTT target of 1.5-2.5 times control)	|  

 <small>*Low molecular weight heparin (LMWH) may not prolong PTT. Anti-factor Xa assay should be used.<br/>See [https://labtestsonline.org/understanding/analytes/aptt/tab/test/]  (https://labtestsonline.org/understanding/analytes/aptt/tab/test/) for more information about PT and PTT.</small>
